ASPET Discovery

Elsevier

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

ASPET Discovery is an open-access journal published by Elsevier in United States, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 3,100 USD. Declared review time at DOAJ: 19 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Elsevier
ISSN
3050-5674
Country
United States
Languages
english
Access
Open access
Declared publication charge
3,100 USD
Articles in DOAJ
19
Declared review time
19 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2026-03-09
Indexing
DOAJ
APC
3,100 USD
Declared review time (DOAJ)
19 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

19

Most recent article

4 months ago

Average review time (journal-declared via DOAJ)

19weeks

Works in OpenAlex

30

Last recorded publication year

2025

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

4

i10-index

1

From OpenAlex open data (CC0).

Editorial & policy10
Added to DOAJ
2026-03-09
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSPortico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Open references deposited at Crossref
97%
ORCID iDs in current deposits
84%
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
9918994891106676
Classification2

Subjects (DOAJ)

Medicine: Therapeutics. Pharmacology

LCC codes

RM1-950

Subject areas

  • Computational Drug Discovery Methods
  • Computational Drug Discovery Methods
  • Protein Degradation and Inhibitors
  • Drug Transport and Resistance Mechanisms
  • Synthesis and biological activity
  • Click Chemistry and Applications
  • Cancer, Hypoxia, and Metabolism
  • Protein Kinase Regulation and GTPase Signaling
Show all subjects (50)
  • Synthesis and biological activity
  • Peptidase Inhibition and Analysis
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Protein Degradation and Inhibitors
  • Cancer therapeutics and mechanisms
  • HER2/EGFR in Cancer Research
  • Acute Myeloid Leukemia Research
  • Acute Myeloid Leukemia Research
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Pharmacogenetics and Drug Metabolism
  • Drug Transport and Resistance Mechanisms
  • HER2/EGFR in Cancer Research
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Peptidase Inhibition and Analysis
  • Cancer therapeutics and mechanisms
  • Melanoma and MAPK Pathways
  • Cancer, Hypoxia, and Metabolism
  • Protein Kinase Regulation and GTPase Signaling
  • Glioma Diagnosis and Treatment
  • Gut microbiota and health
  • Nanoparticles: synthesis and applications
  • Lung Cancer Treatments and Mutations
  • Phytochemicals and Antioxidant Activities
  • Parkinson's Disease Mechanisms and Treatments
  • Alzheimer's disease research and treatments
  • Epilepsy research and treatment
  • Glioma Diagnosis and Treatment
  • Chronic Kidney Disease and Diabetes
  • Neurotransmitter Receptor Influence on Behavior
  • Neuroscience and Neuropharmacology Research
  • Pharmacogenetics and Drug Metabolism
  • Essential Oils and Antimicrobial Activity
  • Gut microbiota and health
  • Nanoparticles: synthesis and applications
  • Parkinson's Disease Mechanisms and Treatments
  • Alzheimer's disease research and treatments
  • Phytochemicals and Antioxidant Activities
  • Epilepsy research and treatment
  • Essential Oils and Antimicrobial Activity
  • Neurotransmitter Receptor Influence on Behavior
  • Neuroscience and Neuropharmacology Research

Keywords (DOAJ)

  • pharmacology
  • experimental therapeutics
  • drug absorption
  • distribution
  • metabolism
  • disposition (adme)

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: